Metabolomics as a tool to stratify patients and guide therapeutic decisions

YouTube

By loading the video, you agree to YouTube’s privacy policy.
Learn more

Load video

Speaker | Stefan Ledinger, MA BSc

Affiliation | biocrates life sciences, Innsbruck, Austria


Metabolomics as a tool to stratify patients and guide therapeutic decisions

In spite of major advances in the treatment of numerous diseases, non-response and loss of response to therapy is still an important topic. In addition, actionable biomarkers are largely missing for indications beyond oncology, as well as for the choice of supportive therapy. Here, metabolomics can be used to develop tools to help guide therapy decisions in multiple ways, e.g. predict whether a drug will be effective, choose the best course of therapy, or monitor therapies along the patient journey.

Related videos

Host-microbial interactions as pathophysiological nexus in inflammatory bowel disease
Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancer


Related articles